Literature DB >> 11101003

Effects of tamoxifen on the electron transport chain of isolated rat liver mitochondria.

C Tuquet1, J Dupont, A Mesneau, J Roussaux.   

Abstract

Tamoxifen (and 4-hydroxytamoxifen), a nonsteroidal triphenylethylene antiestrogenic drug widely used in the treatment of breast cancer, interacts strongly with the respiratory chain of isolated rat liver mitochondria. The drug acts as both an uncoupling agent and a powerful inhibitor of electron transport. Tamoxifen brings about a collapse of the membrane potential. Enzymatic assays and spectroscopic studies indicate that tamoxifen inhibits electron transfer in the respiratory chain at the levels of complex III (ubiquinol-cytochrome-c reductase) and, to a lesser extent, of complex IV (cytochrome-c oxidase). The activities can be restored by the addition of diphosphatidylglycerol, a phospholipid implicated in the functioning of the respiratory chain complexes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11101003     DOI: 10.1023/a:1007695308257

Source DB:  PubMed          Journal:  Cell Biol Toxicol        ISSN: 0742-2091            Impact factor:   6.691


  23 in total

1.  Measuring interference of drug-like molecules with the respiratory chain: toward the early identification of mitochondrial uncouplers in lead finding.

Authors:  Ursula Stock; Hans Matter; Kerstin Diekert; Wolfgang Dörner; Stefan Dröse; Thomas Licher
Journal:  Assay Drug Dev Technol       Date:  2013-08-30       Impact factor: 1.738

Review 2.  Tamoxifen use for the management of mania: a review of current preclinical evidence.

Authors:  Fernanda Armani; Monica Levy Andersen; José Carlos Fernandes Galduróz
Journal:  Psychopharmacology (Berl)       Date:  2014-01-18       Impact factor: 4.530

3.  Systematic Identification of MCU Modulators by Orthogonal Interspecies Chemical Screening.

Authors:  Daniela M Arduino; Jennifer Wettmarshausen; Horia Vais; Paloma Navas-Navarro; Yiming Cheng; Anja Leimpek; Zhongming Ma; Alba Delrio-Lorenzo; Andrea Giordano; Cecilia Garcia-Perez; Guillaume Médard; Bernhard Kuster; Javier García-Sancho; Dejana Mokranjac; J Kevin Foskett; M Teresa Alonso; Fabiana Perocchi
Journal:  Mol Cell       Date:  2017-08-17       Impact factor: 17.970

4.  Mitochondrial dysfunction and apoptosis underlie the hepatotoxicity of perhexiline.

Authors:  Zhen Ren; Si Chen; Ji-Eun Seo; Xiaoqing Guo; Dongying Li; Baitang Ning; Lei Guo
Journal:  Toxicol In Vitro       Date:  2020-08-28       Impact factor: 3.500

5.  Harnessing gene expression to identify the genetic basis of drug resistance.

Authors:  Bo-Juen Chen; Helen C Causton; Denesy Mancenido; Noel L Goddard; Ethan O Perlstein; Dana Pe'er
Journal:  Mol Syst Biol       Date:  2009-10-13       Impact factor: 11.429

Review 6.  Estrogenic control of mitochondrial function and biogenesis.

Authors:  Carolyn M Klinge
Journal:  J Cell Biochem       Date:  2008-12-15       Impact factor: 4.429

Review 7.  Mechanistic review of drug-induced steatohepatitis.

Authors:  Justin D Schumacher; Grace L Guo
Journal:  Toxicol Appl Pharmacol       Date:  2015-09-05       Impact factor: 4.219

Review 8.  Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research.

Authors:  Joost Willebrords; Isabel Veloso Alves Pereira; Michaël Maes; Sara Crespo Yanguas; Isabelle Colle; Bert Van Den Bossche; Tereza Cristina Da Silva; Cláudia Pinto Marques Souza de Oliveira; Wellington Andraus; Venâncio Avancini Alves; Bruno Cogliati; Mathieu Vinken
Journal:  Prog Lipid Res       Date:  2015-06-11       Impact factor: 16.195

9.  Proteomic investigation of the sinulariolide-treated melanoma cells A375: effects on the cell apoptosis through mitochondrial-related pathway and activation of caspase cascade.

Authors:  Hsing-Hui Li; Jui-Hsin Su; Chien-Chih Chiu; Jen-Jie Lin; Zih-Yan Yang; Wen-Ing Hwang; Yu-Kuei Chen; Yu-Hsuan Lo; Yu-Jen Wu
Journal:  Mar Drugs       Date:  2013-07-22       Impact factor: 5.118

10.  Identification of a putative protein profile associated with tamoxifen therapy resistance in breast cancer.

Authors:  Arzu Umar; Hyuk Kang; Annemieke M Timmermans; Maxime P Look; Marion E Meijer-van Gelder; Michael A den Bakker; Navdeep Jaitly; John W M Martens; Theo M Luider; John A Foekens; Ljiljana Pasa-Tolić
Journal:  Mol Cell Proteomics       Date:  2009-03-27       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.